Product and request context
The medicine, presentation, intended destination and available supporting information are considered together rather than as separate details.
Patient-specific access
A considered route for patient-specific medicine access.
When a medicine is not routinely available in the market where it is needed, the route forward depends on the product, the patient-specific context and the applicable local process.
- Named Patient Program
- Orphan medicines
- Case-based coordination
Service overview
Access begins with understanding the request in full.
A patient-specific request often begins where routine commercial supply ends. The same medicine may have a different market status, presentation or authorised route from one country to another. That makes early clarity essential: what is being requested, where it is intended to go and which authorised stakeholders need to take part.
Orphan medicines can add another layer of difficulty. Production may be limited, distribution channels may be narrow and continuity may require more careful planning than a single shipment. We bring availability, remaining shelf life, documentation and transport conditions into the same conversation before a route is defined.
Assessment framework
What shapes the access plan
No two requests should be treated as interchangeable. These are the practical questions that determine whether and how a case can move forward.
Availability and source review
Potential supply is examined with attention to source suitability, remaining shelf life and the prospect of continuity where it matters.
Documents and transport
The information required by the relevant parties and the product’s storage or delivery conditions are incorporated into the plan from the outset.
Working sequence
One request, a clearly defined sequence.
The exact route varies by country and case. Our working sequence keeps the important questions visible and the participating parties aligned.
- 01
Understand the need
Clarify the medicine, presentation, destination, timing and the information already available.
- 02
Assess the possible route
Consider product status, potential sources, shelf life and the parties authorised to participate.
- 03
Align requirements
Identify the documents, storage conditions, transport needs and open points that must be resolved.
- 04
Coordinate handover
Maintain clear communication through preparation, dispatch and transfer to the relevant authorised recipient.
Responsible information
Important access note
Availability and eligibility are confirmed individually. Turkistan Pharma does not provide medical advice through this website, and the information on this page is not a medicine offer or a substitute for the decisions of authorised healthcare and regulatory professionals.
Turkistan Pharma
Discuss a patient-specific access requirement.
Share the product, destination and timing context you currently have. Our team will identify the information needed for an initial assessment.
Share your requirement